Cinqair
Payments companies reported to CMS as associated with Cinqair. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cinqair, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cinqair
These are the largest totals companies reported as associated with Cinqair. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Russoniello | Denville, NJ | Pulmonary Disease | $25.29 |
| Gaurang Patel | Denville, NJ | Pulmonary Disease | $25.29 |
| Mohammad Ghani | Westchester, IL | Allergy | $23.72 |
| Jeffrey Weiss | Riverdale, NJ | Allergy | $22.48 |
| Katie Bogusz | Riverdale, NJ | Allergy & Immunology | $22.48 |
| Gurmit Gill | Garden City, NY | Pulmonary Disease | $20.67 |
| Harry Lee | Montgomery, AL | Allergy & Immunology | $19.74 |
| David Frazer | Montgomery, AL | Allergy & Immunology | $19.74 |
| Gad Avshalomov | Brooklyn, NY | Allergy & Immunology | $19.11 |
| Nina Smith | Syosset, NY | Family | $19.11 |
Prescribed Cinqair?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.